GR79349B - - Google Patents
Info
- Publication number
- GR79349B GR79349B GR72091A GR830172091A GR79349B GR 79349 B GR79349 B GR 79349B GR 72091 A GR72091 A GR 72091A GR 830172091 A GR830172091 A GR 830172091A GR 79349 B GR79349 B GR 79349B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8222019 | 1982-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR79349B true GR79349B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-10-22 |
Family
ID=10532012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR72091A GR79349B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-07-30 | 1983-07-29 |
Country Status (41)
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8320520D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| GB8400024D0 (en) * | 1984-01-03 | 1984-02-08 | Glaxo Group Ltd | Cephalosporin antibiotics |
| GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| US5017380A (en) * | 1986-07-02 | 1991-05-21 | Shionogi & Co., Ltd. | Gelatin hard capsule containing crystalline hydrate of oral cephalosporin |
| NZ220764A (en) * | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
| NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
| CA1339136C (en) * | 1987-07-01 | 1997-07-29 | Sailesh Amilal Varia | Amorphous form of aztreonam |
| GB8810394D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
| IT1230095B (it) * | 1989-04-27 | 1991-10-05 | Parenta Srl | Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici. |
| AT393955B (de) * | 1990-03-30 | 1992-01-10 | Martin Dr Leixnering | Einrichtung zur nachbehandlung frischer beugesehnenverletzungen |
| US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
| IT1277426B1 (it) * | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | Forma cristallina biodisponibile del cefuroxima axetil |
| NZ299077A (en) * | 1996-07-26 | 1998-06-26 | Apotex Inc | Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf |
| IT1289955B1 (it) * | 1997-02-21 | 1998-10-19 | Solchem Italiana Spa | Acyclovir sale sodico biidrato e sua preparazione |
| KR100187959B1 (ko) * | 1997-03-31 | 1999-06-01 | 윤재승 | 저융점 무정형 세푸록심 악세틸의 제조방법 |
| CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| IN186539B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd | |
| GB9726781D0 (en) * | 1997-12-19 | 1998-02-18 | Glaxo Group Ltd | Pharmaceutical composition |
| DE19907521A1 (de) * | 1998-02-20 | 1999-11-04 | Fako Ilaclari A S | Lösliches kristallines Cefuroxim axetil |
| DE69905452D1 (de) * | 1998-03-03 | 2003-03-27 | Daewoong Pharmaceutical Co | Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen |
| KR100299356B1 (ko) * | 1998-03-03 | 2001-10-27 | 윤재승 | 수분흡수에대해안정한세푸록심악세틸함유제약조성물 |
| CA2239331C (en) * | 1998-05-29 | 1999-11-30 | Bernard Charles Sherman | Pharmaceutical tablets comprising cefuroxime axetil |
| US6384213B1 (en) | 1998-10-23 | 2002-05-07 | Ranbaxy Laboratories Limited | Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| KR100363566B1 (ko) * | 1998-11-20 | 2003-08-19 | 국제약품공업주식회사 | 무정형 세푸록심 악세틸의 제조방법 |
| AT413647B (de) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
| BR0009177A (pt) | 1999-03-19 | 2002-01-22 | Ranbaxy Lab Ltd | Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima |
| IN191492B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| IN191236B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-05-25 | 2003-10-11 | Ranbaxy Lab Ltd | |
| US6930983B2 (en) * | 2000-03-15 | 2005-08-16 | Texas Instruments Incorporated | Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications |
| CA2280925A1 (en) | 1999-07-29 | 2001-01-29 | Bernard Charles Sherman | Stabilized cefuroxime axetil |
| IN191496B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-07-30 | 2003-12-06 | Ranbaxy Lab Ltd | |
| KR100342943B1 (ko) * | 1999-08-04 | 2002-07-02 | 민경윤 | 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물 |
| JP2001131071A (ja) * | 1999-10-29 | 2001-05-15 | Meiji Seika Kaisha Ltd | 非晶質および非晶質を含有する医薬組成物 |
| KR100357816B1 (ko) * | 2000-05-09 | 2002-10-18 | 보령제약 주식회사 | 무정형 세푸록심 악세틸의 제조 및 이의 분리방법 |
| IN190849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2000-07-17 | 2003-08-23 | Ranbaxy Lab Ltd | |
| KR20020016052A (ko) * | 2000-08-24 | 2002-03-04 | 최현식 | 무정형 세푸록심 악세틸의 제조방법 |
| AT411996B (de) * | 2000-09-11 | 2004-08-26 | Sandoz Ag | Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes |
| KR100399195B1 (ko) * | 2001-03-17 | 2003-09-26 | 신풍제약주식회사 | 무정형 세푸록심 악세틸의 제조방법 |
| ITMI20011763A1 (it) * | 2001-08-10 | 2003-02-10 | Antibioticos Spa | Processo di preparazione di cefuroxime axelite ad elevata purezza |
| ITMI20011766A1 (it) * | 2001-08-10 | 2003-02-10 | A & G Soluzioni Digitali S R L | Dispositivo e metodo per la simulazione della presenza di una o piu' sorgenti di suoni in posizioni virtuali nello spazio acustico a tre dim |
| AU2002340847B2 (en) * | 2001-09-10 | 2007-09-13 | F. Hoffmann-La Roche Ag | Oily thixotropic formulations |
| ITMI20011925A1 (it) * | 2001-09-14 | 2003-03-14 | Antibioticos Spa | Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino |
| GB2383042A (en) * | 2001-10-18 | 2003-06-18 | Cipla Ltd | Amorphous alendronate sodium |
| ES2201932B2 (es) * | 2001-11-23 | 2005-03-16 | Glaxo Group Limited | Composicion farmaceutica. |
| US7034162B2 (en) * | 2002-08-12 | 2006-04-25 | Dr. Reddy's Laboratories Limited | Amorphous form of 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methane sulfonamide succinate (sumatriptan succinate) |
| US6911441B2 (en) * | 2002-12-16 | 2005-06-28 | Akzo Nobel N.V. | Prolonged release pharmaceutical composition |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US20070054953A1 (en) * | 2003-05-12 | 2007-03-08 | Potluri Ramesh B | A novel process for preparation of indole derivatives |
| US20050079213A1 (en) * | 2003-06-06 | 2005-04-14 | Unilab Pharmatech Ltd | Pharmaceutical compositions |
| KR100552567B1 (ko) * | 2003-08-23 | 2006-02-15 | 한국유나이티드제약 주식회사 | 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법 |
| JP2007517864A (ja) * | 2004-01-09 | 2007-07-05 | ハンミ ファーム． シーオー．， エルティーディー． | セフロキシムアキセチル顆粒及びこの製造方法 |
| US7633033B2 (en) * | 2004-01-09 | 2009-12-15 | General Lasertronics Corporation | Color sensing for laser decoating |
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
| DE102005019458A1 (de) | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
| US8900637B2 (en) * | 2005-12-02 | 2014-12-02 | Lupin Limited | Stable taste masked formulations of cephalosporins |
| US20070128268A1 (en) * | 2005-12-07 | 2007-06-07 | Herwig Jennewein | Pharmaceutical compositions comprising an antibiotic |
| SE529796C2 (sv) * | 2006-02-08 | 2007-11-27 | Optoskand Ab | Fiberoptiskt kontaktdon |
| US10112257B1 (en) | 2010-07-09 | 2018-10-30 | General Lasertronics Corporation | Coating ablating apparatus with coating removal detection |
| EP2741750A1 (en) | 2011-08-12 | 2014-06-18 | Dhanuka Laboratories Ltd. | Pharmaceutical composition comprising cefuroxime |
| US9895771B2 (en) | 2012-02-28 | 2018-02-20 | General Lasertronics Corporation | Laser ablation for the environmentally beneficial removal of surface coatings |
| EP2833873A1 (en) | 2012-04-04 | 2015-02-11 | Mahmut Bilgic | Film tablet formulations comprising cefuroxime axetil and clavulanic acid |
| US10086597B2 (en) | 2014-01-21 | 2018-10-02 | General Lasertronics Corporation | Laser film debonding method |
| CN105131016A (zh) * | 2015-08-04 | 2015-12-09 | 江苏正大清江制药有限公司 | 一种头孢呋辛酯的制备方法 |
| CN116284050B (zh) * | 2022-12-19 | 2024-04-12 | 华北制药河北华民药业有限责任公司 | 一种高效率结晶型头孢呋辛酯转无定型粉体的方法及产品 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4029655A (en) * | 1975-04-11 | 1977-06-14 | Eli Lilly And Company | Method of preparing stable sterile crystalline cephalosporins for parenteral administration |
| US4002748A (en) * | 1976-01-19 | 1977-01-11 | Eli Lilly And Company | Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration |
| CA1094545A (en) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| GB1572993A (en) * | 1976-02-16 | 1980-08-13 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| GB1598568A (en) * | 1977-04-19 | 1981-09-23 | Glaxo Lab Ltd | Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid |
| JPS5559194A (en) * | 1978-09-21 | 1980-05-02 | Glaxo Group Ltd | Manufacture of cephalosporin compound |
| JPS5562714A (en) * | 1978-11-01 | 1980-05-12 | Hitachi Ltd | Garnet film for magnetic bubble |
| ES484321A1 (es) * | 1979-04-06 | 1980-10-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de un compuesto de 3- carbamoiloximetil-cefalosporina |
| US4444686A (en) * | 1982-01-25 | 1984-04-24 | Pfizer Inc. | Crystalline penicillin ester intermediate |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
-
1983
- 1983-07-19 YU YU1558/83A patent/YU44680B/xx unknown
- 1983-07-29 KR KR1019830003535A patent/KR910000046B1/ko not_active Expired
- 1983-07-29 AU AU17417/83A patent/AU566881B2/en not_active Expired
- 1983-07-29 NZ NZ205083A patent/NZ205083A/en unknown
- 1983-07-29 ES ES524590A patent/ES524590A0/es active Granted
- 1983-07-29 CA CA000433554A patent/CA1240313A/en not_active Expired
- 1983-07-29 HU HU832715A patent/HU190603B/hu unknown
- 1983-07-29 ZA ZA835579A patent/ZA835579B/xx unknown
- 1983-07-29 EP EP83304405A patent/EP0107276B1/en not_active Expired
- 1983-07-29 FR FR8312561A patent/FR2531087B1/fr not_active Expired
- 1983-07-29 LU LU84935A patent/LU84935A1/fr unknown
- 1983-07-29 ZW ZW173/83A patent/ZW17383A1/xx unknown
- 1983-07-29 JP JP58137871A patent/JPH0730084B2/ja not_active Expired - Lifetime
- 1983-07-29 NL NL8302705A patent/NL8302705A/nl not_active Application Discontinuation
- 1983-07-29 DE DE19833327449 patent/DE3327449A1/de not_active Withdrawn
- 1983-07-29 IE IE1804/83A patent/IE55748B1/en not_active IP Right Cessation
- 1983-07-29 AT AT0276783A patent/AT382154B/de not_active IP Right Cessation
- 1983-07-29 IL IL69375A patent/IL69375A/xx not_active IP Right Cessation
- 1983-07-29 CS CS835687A patent/CS259515B2/cs unknown
- 1983-07-29 GB GB08320518A patent/GB2127401B/en not_active Expired
- 1983-07-29 DE DE8383304405T patent/DE3374010D1/de not_active Expired
- 1983-07-29 BE BE0/211274A patent/BE897422A/fr unknown
- 1983-07-29 PT PT77135A patent/PT77135B/pt unknown
- 1983-07-29 DK DK349083A patent/DK164507C/da not_active IP Right Cessation
- 1983-07-29 NO NO832773A patent/NO163897C/no not_active IP Right Cessation
- 1983-07-29 FI FI832757A patent/FI76093C/fi not_active IP Right Cessation
- 1983-07-29 SE SE8304208A patent/SE453195B/sv not_active IP Right Cessation
- 1983-07-29 US US06/518,693 patent/US4562181A/en not_active Expired - Lifetime
- 1983-07-29 IT IT48789/83A patent/IT1168206B/it active Protection Beyond IP Right Term
- 1983-07-29 CH CH4180/83A patent/CH657134A5/de not_active IP Right Cessation
- 1983-07-29 GR GR72091A patent/GR79349B/el unknown
- 1983-07-29 SU SU833624504A patent/SU1266471A3/ru active
- 1983-07-29 PL PL1983243228A patent/PL156001B1/pl unknown
-
1986
- 1986-12-04 US US06/938,140 patent/US4820833A/en not_active Expired - Lifetime
-
1987
- 1987-12-30 MY MY58/87A patent/MY8700058A/xx unknown
-
1988
- 1988-03-30 KE KE3805A patent/KE3805A/xx unknown
- 1988-04-14 SG SG260/88A patent/SG26088G/en unknown
- 1988-09-02 CY CY1434A patent/CY1434A/en unknown
- 1988-10-18 US US07/258,908 patent/US5013833A/en not_active Expired - Lifetime
- 1988-10-18 US US07/258,886 patent/US4994567A/en not_active Expired - Lifetime
- 1988-10-20 HK HK842/88A patent/HK84288A/xx not_active IP Right Cessation
-
1990
- 1990-03-14 DO DO1990004773A patent/DOP1990004773A/es unknown
-
1991
- 1991-12-23 SK SK4031-91A patent/SK277896B6/sk unknown
- 1991-12-23 CZ CS914031A patent/CZ280528B6/cs unknown
-
1992
- 1992-05-25 DK DK92683A patent/DK68392D0/da not_active Application Discontinuation
-
1994
- 1994-05-26 EC EC1994001098A patent/ECSP941098A/es unknown